Ranking by Regions
United States
Canada
Mexico
Brazil
Chile
Germany
United Kingdom
France
Spain
Netherlands
Sweden
Italy
Switzerland
Poland
Finland
China
Japan
South Korea
Hong Kong
Singapore
Indonesia
India
Malaysia
Taiwan
Thailand
Australia
New Zealand
Israel
Saudi Arabia
Turkey
Russia
South AfricaRanking by categories
As of April 16, 2025, Iovance Biotherapeutics (IOVA) has a market cap of $1.02 billion USD. According to our data, Iovance Biotherapeutics is ranked No.5022 in global market value.
| Year | Market Cap | %Change |
|---|---|---|
| Apr 16, 2025 | $1.02 B |
-54.93%
|
| Dec 31, 2024 | $2.26 B |
-8.98%
|
| Dec 29, 2023 | $2.48 B |
27.23%
|
| Dec 30, 2022 | $1.95 B |
-66.53%
|
| Dec 31, 2021 | $5.82 B |
-58.86%
|
| Dec 31, 2020 | $14.14 B |
67.63%
|
| Dec 31, 2019 | $8.44 B |
212.77%
|
| Dec 31, 2018 | $2.70 B |
10.63%
|
| Dec 29, 2017 | $2.44 B |
15.11%
|
| Dec 30, 2016 | $2.12 B |
-9.97%
|
| Dec 31, 2015 | $2.35 B |
-1.91%
|
| Dec 31, 2014 | $2.40 B |
-25.05%
|
| Dec 31, 2013 | $3.20 B |
-52.27%
|
| Dec 31, 2012 | $6.71 B |
-78.00%
|
| Dec 30, 2011 | $30.48 B |
-20.00%
|
| Dec 31, 2010 | $38.10 B |
100%
|
| Name | Market Cap | Market cap difference | Regions |
|---|---|---|---|
 Adaptimmune Therapeutics
ADAP
|
$62.15 M |
-2.161 M
|
UK
|
 bluebird bio
BLUE
|
$41.02 M |
-2.741 M
|
USA
|
 Cellectis
CLLS
|
$0.21 B |
60.605 M
|
France
|
 Atara Biotherapeutics
ATRA
|
$34.22 M |
-0.820 M
|
USA
|
 Fate Therapeutics
FATE
|
$0.12 B |
-4.011 M
|
USA
|
 Autolus Therapeutics
AUTL
|
$0.36 B |
-0.016 B
|
UK
|
 Allogene Therapeutics
ALLO
|
$0.31 B |
-9.777 M
|
USA
|
 CRISPR Therapeutics
CRSP
|
$3.22 B |
-0.124 B
|
Switzerland
|
 Intellia Therapeutics
NTLA
|
$0.73 B |
-0.036 B
|
USA
|
| Market Cap | = | IOVA Stock Price | * | IOVA Shares Outstanding |
| = | $3.10 | * | 0.33 B | |
| = | $1.02 B |